Home/Healthcare/Medical Devices/Global Medical Gas Market

Global Medical Gas Market - Strategic Insights and Forecasts (2026-2031)

Market Size, Share, Forecasts and Analysis By Gas Type (Oxygen, Nitrogen, Carbon Dioxide, Others), By Application (Therapeutic, Diagnostic, Surgery, Others), By End-User (Hospitals & Clinics, Surgical Centers, Others), and Geography

Market Size in 2025
USD 16.38 billion
Market Size in 2031
USD 22.63 billion
CAGR
5.54%
Study Period
2020-2031
$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

Medical Gas Market is projected to grow at a 5.54% CAGR, increasing from USD 16.38 billion in 2025 to USD 22.63 billion in 2031.

Global Medical Gas Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $16.38B in 2025 to $22.63B by 2031 at a CAGR of 5.54%.
Global Medical Gas Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $16.38B in 2025 to $22.63B by 2031 at a CAGR of 5.54%.

Highlights:

  1. 1
    Increasing chronic diseases are boosting medical gas demand globally.
  2. 2
    Advancements in ECMO and oxygen therapy devices are improving patient care.
  3. 3
    Asia-Pacific region is expanding rapidly with strengthened healthcare infrastructure.
  4. 4
    Enhanced supply chain partnerships and investments support market growth.

Within healthcare, medical gases encompass any gases or gas mixtures specifically intended for medicinal purposes. These gases play an indispensable role in a diverse array of medical procedures and treatments, spanning from critical life-saving resuscitation efforts to pain management interventions and diagnostic testing. Among the various types of medical gases, oxygen stands out as the most prevalent, serving as a fundamental support for cellular respiration and proving vital for patients with respiratory challenges. Carbon dioxide finds application in diverse medical scenarios, from inflating surgical cavities to stimulating breathing and regulating blood acidity.

Nitrous oxide, commonly known as laughing gas, serves as a prominent analgesic and sedative during dental procedures and childbirth. Nitrogen finds utility in cryosurgery, where its extreme cold is leveraged to destroy unwanted tissue, as well as in the preservation of blood and organs for transplantation. Anaesthetic gases, comprising mixtures like halothane, isoflurane, and sevoflurane, are instrumental in inducing and maintaining anesthesia during surgical procedures. These medical gases collectively contribute to the intricate landscape of healthcare, facilitating a broad spectrum of therapeutic and diagnostic applications.

Medical Gas Market Growth Drivers:

  • Increasing prevalence of chronic diseases

Globally, there is a notable trend toward an evolving lifestyle, and this is particularly evident in the rise of chronic ailments in the population. In the United States, the demographic aged 50 years and older is projected to surge by 61.11% from 137.25 million in 2020 to 221.13 million in 2050. Concurrently, the prevalence of chronic diseases within this age group is estimated to escalate by 99.5%, reaching 142.66 million by 2050. Heart disease, affecting over 79 million Americans, stands as a significant contributor to 40% of all deaths. In the European Union (EU), 36.1% of the population reported having chronic health problems in 2022. Noncommunicable diseases (NCDs), particularly cardiovascular diseases, cancer, diabetes, and chronic respiratory ailments impose a substantial and growing health burden in the Southeast Asia Region, accounting for 62% of all deaths, totalling 9 million individuals. This rise in respiratory diseases, cardiovascular conditions, chronic pain, and related health issues intensifies the demand for medical gases like oxygen, nitrous oxide, and helium, crucial for effective treatment and pain management.

  • Advancements in equipment and technologies

A primary catalyst propelling the medical gas market forward is the continuous evolution of equipment and technologies. One noteworthy advancement is the utilization of Extracorporeal Membrane Oxygenation (ECMO), a life-saving technology designed to provide temporary support to the heart and lungs during critical care scenarios. ECMO employs a specialized circuit that oxygenates the blood outside the body, affording the lungs and heart a period of rest and recovery. This innovative technology has proven instrumental in managing challenging medical situations.

Another driving force behind market growth is the integration of nebulizers and high-flow oxygen therapy devices. These tools leverage compressed air or oxygen to deliver medications or enhance airflow, particularly beneficial for patients grappling with respiratory difficulties. The seamless fusion of these cutting-edge technologies underscores the pivotal role of advancements in equipment and technologies in steering the upward trajectory of the medical gas market.

Medical Gas Market Challenges

  • Price volatility is a major challenge

The fluctuation in raw material prices, especially for crucial elements like helium and nitrogen, introduces a level of volatility that can considerably influence both production costs and overall market stability. The unpredictability in pricing for these essential raw materials poses challenges for industries reliant on them, necessitating strategic management and adaptability to navigate potential cost variations and uphold stability in the market. Several factors contribute to this volatility, such as changes in the production or importation of gas, which forms a significant portion of the available gas supply for consumption. Storage plays a pivotal role as a buffer between demand and current supply, serving as an indicator of the relative supply and demand conditions in the gas market. Additionally, constraints within the pipeline delivery system may arise or be alleviated, impacting supply and distribution capabilities. The intricacies of these factors require careful consideration by market participants for effective management in the face of evolving conditions.

Medical Gas Market Segment Analysis:

  • The medical gas market by application is segmented into therapeutic and diagnostics

The medical gas market is segmented by application into two primary categories: therapeutic and diagnostics. In therapeutic applications, medical gases are utilized for treating and managing various medical conditions, providing crucial support in areas such as respiratory therapy, pain management, and life support interventions. Diagnostic applications involve the use of medical gases in procedures and tests aimed at identifying and assessing medical conditions, contributing to the accuracy and efficacy of diagnostic processes in healthcare settings.

Medical Gas Market Geographical Outlook:

  • APAC is anticipated to hold a significant share of the medical gas market

APAC is projected to account for a notable share of the medical gas market. Notably, in India, the Union Budget for 2023-24 has allocated Rs. 89,155 crore (US$ 10.76 billion) to the Ministry of Health and Family Welfare, reflecting a 3.43% increase compared to the previous year. Specific allocations include Rs. 3,365 crore (US$ 0.41 billion) for the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) and Rs. 6,500 crore (US$ 780 million) for Human Resources for Health and Medical Education.

In China, the healthcare sector has seen substantial growth, with successive governments contributing to the establishment of 1,030,935 healthcare institutions on the mainland by the end of 2021. This includes 36,570 hospitals and 977,790 primary-level clinics, organized within a three-tier system based on their capabilities in medical care, education, and research. The collective efforts in advancing healthcare infrastructure are expected to fuel the expansion of both the overall healthcare sector and the medical gas market in the region.

List of Top Medical Gas Companies:

  • Respiratory Oxygen-  The company manufactures medical oxygen adhering to rigorous production and transport regulatory standards. Their purity specifications align with U.S. Pharmacopeia (USP) guidelines, and their manufacturing sites strictly adhere to Good Manufacturing Practice (cGMP) guidelines, complying with GMP standards in Canada. Moreover, their manufacturing process holds ISO 9001:2008 certification, ensuring a commitment to quality and efficiency. Dedicated tankers specifically allocated for medical service are employed to eliminate any potential cross-contamination risks. A team of medical specialists from the company is available to assist healthcare facilities in determining the optimal supply option tailored to their unique needs.

  • Oxygen (O?)- Oxygen (O?), employed as an oxidizing gas, finds essential applications in sustaining life and optimizing performance. Air Products stands out as a world-leading supplier of oxygen, recognized for its global manufacturing capabilities and dependable provision of industrial gases. With a proven track record of meeting on-time needs, Air Products is an industry leader in safety, offering technical support and world-class customer service. For larger operations, the company provides CryoEase® microbulk solutions, presenting a convenient and cost-effective solution. Available in various sizes, CryoEase® tanks further enhance the accessibility and flexibility of oxygen supply, showcasing Air Products' commitment to meeting diverse industrial demands.

  • HyCO – Syngas- MATHESON offers comprehensive expertise with a global reach in the production of hydrogen (H2), carbon monoxide (CO), and syngas. Catering to customers requiring these gases, whether individually or in combination (HyCO or syngas), MATHESON provides Over-The-Fence (OTF) supply services. This entails the generation of gases on site and/or supply through pipelines, ensuring a reliable and efficient source for diverse industrial needs. The company's proficiency extends to the seamless delivery of hydrogen, carbon monoxide, and syngas, aligning with the specific requirements of its clientele on a global scale.

Medical Gas Market Scope

Report Metric Details
Total Market Size in 2025 USD 16.38 billion
Total Market Size in 2031 USD 22.63 billion
Forecast Unit Billion
Growth Rate 5.54%
Study Period 2020 to 2031
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2031
Segmentation Gas Type, Application, End-User, Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies
  • Linde plc.
  • Air Liquide
  • Atlas Copco
  • Messer
  • Air Products and Chemicals Inc.

Market Segmentation

By Gas Type

Oxygen
Nitrogen
Carbon Dioxide
Others

By Application

Therapeutic
Diagnostic
Surgery
Others

By End-user

Hospitals & Clinics
Surgical Centers
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Italy
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

Table of Contents

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MEDICAL GAS MARKET BY GAS TYPE

5.1. Introduction

5.2. Oxygen

5.3. Nitrogen

5.4. Carbon Dioxide

5.5. Others

6. MEDICAL GAS MARKET BY APPLICATION

6.1. Introduction

6.2. Therapeutic

6.3. Diagnostic

6.4. Surgery

6.5. Others

7. MEDICAL GAS MARKET BY END-USER

7.1. Introduction

7.2. Hospitals & Clinics

7.3. Surgical Centers

7.4. Others

8. MEDICAL GAS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Gas Type

8.2.2. By Application

8.2.3. By End-User

8.2.4. By Country

8.2.4.1. USA

8.2.4.2. Canada

8.2.4.3. Mexico

8.3. South America

8.3.1. By Gas Type

8.3.2. By Application

8.3.3. By End-User

8.3.4. By Country

8.3.4.1. Brazil

8.3.4.2. Argentina

8.3.4.3. Others

8.4. Europe

8.4.1. By Gas Type

8.4.2. By Application

8.4.3. By End-User

8.4.4. By Country

8.4.4.1. Germany

8.4.4.2. France

8.4.4.3. United Kingdom

8.4.4.4. Spain

8.4.4.5. Italy

8.4.4.6. Others

8.5. Middle East and Africa

8.5.1. By Gas Type

8.5.2. By Application

8.5.3. By End-User

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.2. UAE

8.5.4.3. Others

8.6. Asia Pacific

8.6.1. By Gas Type

8.6.2. By Application

8.6.3. By End-User

8.6.4. By Country

8.6.4.1. China

8.6.4.2. India

8.6.4.3. Japan

8.6.4.4. South Korea

8.6.4.5. Indonesia

8.6.4.6. Thailand

8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Matheson Tri-Gas, Inc.

10.2. Linde plc.

10.3. Air Liquide

10.4. Atlas Copco

10.5. Messer

10.6. Air Products and Chemicals Inc.

10.7. Taiyo Nippon Sanso Corporation (Mitsubishi Chemical Group)

10.8. INOX-Air Products Inc.

10.9. SOL Spa

10.10. NOVAIR SAS

11. APPENDIX

11.1. Currency

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology

11.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061616314
PublishedMar 2026
Pages143
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

The Global Medical Gas Market is projected to increase from USD 16.38 billion in 2025 to USD 22.63 billion in 2031. This growth represents a Compound Annual Growth Rate (CAGR) of 5.54% over the forecast period, reflecting a steady expansion in demand.

The primary growth driver is the increasing prevalence of chronic diseases globally, including respiratory diseases, cardiovascular conditions, and chronic pain. The report highlights a significant escalation in chronic ailments, such as a projected 99.5% increase in prevalence within the US demographic aged 50 years and older by 2050, intensifying the demand for medical gases like oxygen and nitrous oxide.

The report highlights several key medical gases including oxygen, noted as the most prevalent for respiratory challenges, and carbon dioxide for surgical inflation and stimulating breathing. Nitrous oxide serves as an analgesic, nitrogen is crucial for cryosurgery and organ preservation, and various anaesthetic gases like halothane, isoflurane, and sevoflurane are essential for surgical procedures.

The Asia-Pacific region is identified as expanding rapidly within the medical gas market. This growth is attributed to strengthened healthcare infrastructure across the region, indicating increased investment and development in medical facilities and services that drive demand for medical gases.

Strategic insights influencing the market's future outlook include significant advancements in ECMO and oxygen therapy devices, which are enhancing patient care outcomes. Additionally, enhanced supply chain partnerships and increased investments are supporting overall market growth and improving the availability and distribution of medical gases globally.

Medical gases are indispensable for a broad spectrum of medical procedures and treatments. These include critical life-saving resuscitation efforts, effective pain management interventions, diverse diagnostic testing, and the induction and maintenance of anesthesia during surgical procedures. They are also vital for supporting cellular respiration and treating patients with respiratory challenges.

Need data specifically for your business?Request Custom Research →
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon